I promised more about this when/if it actually happened, so here it is: I began my participation in a new clinical trial on Monday.
I’m not permitted to say much about it right now. It’s a 32 day clinical trial testing a new continuous glucose monitor (CGM). I’m basically wearing the current version of the CGM that’s available to consumers today for the length of the trial. For about a week during this process, I’ll be wearing the new, investigative, not-yet-available-to-the-public version. There’s also an outpatient visit with the research team that will involve, among other things, intentionally inducing both hyperglycemia and hypoglycemia. Under professional medical supervision, of course. This ain’t Flatliners, man. That will happen in about two weeks.
The interesting thing about this CGM trial is that it could definitely have implications for artificial pancreas testing. More to be revealed on that as soon as I can reveal it.
Even though I was bummed about testing out of an artificial pancreas trial, and this opportunity sort of feels like a “lovely parting gift, thank you for playing”, it’s still great that I can participate in this kind of research. Testing the latest CGM technology? Check. Helping AP testing move forward (I hope)? Check. Helping to make things better for People With Diabetes? Check. What more could I ask for?
Whether I play a large or small role in research, what’s important to me is that I help move the needle each time I participate, even if that’s just a little bit each time. When I have more to tell, and I’m allowed to tell it, I’ll let you know.